Inspecs Group PLC
LSE:SPEC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (29.4), the stock would be worth GBX47.65 (43% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 51.5 | GBX83.5 |
0%
|
| 3-Year Average | 29.4 | GBX47.65 |
-43%
|
| 5-Year Average | 31.6 | GBX51.19 |
-39%
|
| Industry Average | 0 | GBX0.08 |
-100%
|
| Country Average | 0 | GBX0.06 |
-100%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Inspecs Group PLC
LSE:SPEC
|
84.9m GBP | 51.5 | -10.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 46.8 | 39.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
59.4B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.9B CHF | 24.5 | 37.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
93.1B DKK | 20.9 | 23.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.2B USD | 24.6 | 32.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 25 | 32.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | -155.5 | -15.6 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.8B CNY | -32 | 22.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
879B JPY | 24.7 | 49.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.3B CNY | 31.2 | 22.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0.1 |
| Max | 1 344.9 |
Other Multiples
Inspecs Group PLC
Glance View
Inspecs Group Plc engages in designing, production, selling, marketing, and distribution of fashion eyewear, lenses and OEM products worldwide. The company is headquartered in Bath, Somerset and currently employs 1,800 full-time employees. The company went IPO on 2020-02-27. The firm is a designer, manufacturer and distributor of eyewear frames and optical spectacle lenses. The firm produces a range of frames and lenses, covering optical, sunglasses and safety. The company has operations across the globe, including the United Kingdom, Portugal, Scandinavia, the United States and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the United Kingdom and Italy. The firm also operates across Europe and the American markets. Its customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 70,000 points of sale.
